AXNX News and Press, Axonics Modulation Technologies Inc. From 05/06/19

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , announced the presenta...

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , today announced that m...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The U.S. will send a high-level delegation to Beijing next week as trade negotiatio...

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , today announced t...

Welkin’s software will streamline workflows for care teams and enable personalized, ongoing support for patients receiving therapy for urinary and fecal dysfunction Welkin Health , a privately-held patient relationship management software company today announced it is partneri...

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , today announced that Na...

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , today announced that m...

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , today announced that m...

Axonics Modulation Technologies (AXNX) Q4 2018 Earnings Conference Call March 05, 2019 04:30 PM ET Company Participants Matt Clawson - W2O Group, Investor Relations Ray Cohen - Chief Executive Officer Dan Dearen - President & Chief Financial Officer Karen Noblett - Chief Me...